Aptus Capital Advisors, LLC Novartis Ag Transaction History

Aptus Capital Advisors, LLC

$8.9 Billion
Q4 2024

A detailed history of Aptus Capital Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 16,026 shares of NVS stock, worth $1.75 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

16,026

Previous 4,547 252.45%

Holding current value

$1.75 Million

Previous $522,000 198.66%

% of portfolio

0.02%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$96.78 - $117.18 $1.11 Million - $1.35 Million	11,479 Added 252.45%	16,026 $1.56 Million
Q3 2024 Nov 05, 2024	SELL	$106.13 - $120.89 $7,322 - $8,341	-69 Reduced 1.49%	4,547 $522,000
Q2 2024 Jul 31, 2024	BUY	$92.57 - $107.37 $4,813 - $5,583	52 Added 1.14%	4,616 $491,000
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $59,162 - $67,359	621 Added 15.75%	4,564 $441,000
Q4 2023 Feb 13, 2024	SELL	$92.27 - $101.54 $16,793 - $18,480	-182 Reduced 4.41%	3,943 $398,000
Q3 2023 Nov 08, 2023	BUY	$94.73 - $105.13 $54,848 - $60,870	579 Added 16.33%	4,125 $420,000
Q2 2023 Aug 11, 2023	BUY	$92.52 - $104.91 $93,815 - $106,378	1,014 Added 40.05%	3,546 $357,000
Q1 2023 May 09, 2023	SELL	$80.03 - $92.81 $42,976 - $49,838	-537 Reduced 17.5%	2,532 $232,000
Q4 2022 Feb 13, 2023	BUY	$75.55 - $92.52 $1,964 - $2,405	26 Added 0.85%	3,069 $278,000
Q3 2022 Nov 02, 2022	BUY	$74.61 - $87.26 $20,219 - $23,647	271 Added 9.78%	3,043 $231,000
Q2 2022 Jul 29, 2022	BUY	$80.52 - $93.75 $3,703 - $4,312	46 Added 1.69%	2,772 $234,000
Q1 2022 May 04, 2022	BUY	$80.11 - $90.62 $11,135 - $12,596	139 Added 5.37%	2,726 $239,000
Q3 2021 Oct 27, 2021	SELL	$81.78 - $95.14 $572 - $665	-7 Reduced 0.27%	2,587 $212,000
Q2 2021 Jul 27, 2021	SELL	$85.24 - $94.15 $85 - $94	-1 Reduced 0.04%	2,594 $237,000
Q4 2020 Feb 10, 2021	BUY	$78.07 - $94.43 $78 - $94	1 Added 0.04%	2,595 $245,000
Q3 2020 Oct 19, 2020	SELL	$82.14 - $91.0 $1,396 - $1,547	-17 Reduced 0.65%	2,594 $225,000
Q2 2020 Jul 22, 2020	BUY	$80.93 - $91.1 $1,133 - $1,275	14 Added 0.54%	2,611 $228,000
Q1 2020 May 07, 2020	SELL	$70.67 - $99.01 $17,243 - $24,158	-244 Reduced 8.59%	2,597 $214,000
Q4 2019 Feb 10, 2020	BUY	$84.35 - $95.37 $337 - $381	4 Added 0.14%	2,841 $269,000
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $2,052 - $2,262	-24 Reduced 0.84%	2,837 $246,000
Q2 2019 Aug 13, 2019	SELL	$75.4 - $92.8 $119,132 - $146,624	-1,580 Reduced 35.58%	2,861 $261,000
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $334,496 - $382,592	4,441 New	4,441 $426,000

Others Institutions Holding NVS

# of Institutions

1,474

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $235B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aptus Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aptus Capital Advisors, LLC with notifications on news.

Account

Aptus Capital Advisors, LLC Novartis Ag Transaction History